Cardiac-specific PRMT5 transgenic (PRMT5-TG) mice were generated to evaluate the gain-of-function of PRMT5 in cardiac hypertrophy and dysfunction in male mice undergoing TAC surgery. The gene discussed is PRMT5; the disease is persistent truncus arteriosus.